• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲硝唑对人肠道模型中流行的艰难梭菌PCR核糖体分型001和027生长及毒素产生的影响

Effect of metronidazole on growth and toxin production by epidemic Clostridium difficile PCR ribotypes 001 and 027 in a human gut model.

作者信息

Freeman Jane, Baines Simon D, Saxton Katie, Wilcox Mark H

机构信息

Department of Microbiology, Leeds Teaching Hospital and University of Leeds, Leeds LS1 3EX, UK.

出版信息

J Antimicrob Chemother. 2007 Jul;60(1):83-91. doi: 10.1093/jac/dkm113. Epub 2007 May 5.

DOI:10.1093/jac/dkm113
PMID:17483547
Abstract

OBJECTIVES

We compared the behaviour of Clostridium difficile PCR ribotypes 001 and 027 in a human gut model, and compared the responses to metronidazole exposure.

METHODS

Using a human gut model primed with pooled human faeces, gut flora bacterial counts, C. difficile total viable counts, spore counts and cytotoxin titres were determined, following exposure to clindamycin, in the absence or presence of metronidazole.

RESULTS

Duration of cytotoxin production by C. difficile ribotype 027 was markedly longer than that of ribotype 001 (23 versus 13 days, respectively), but peak toxin titres were similar. During toxin production, total C. difficile ribotype 027 populations had higher proportions of vegetative cells than did ribotype 001 (median 56.33 versus 23.54%). Similarly, total C. difficile ribotype 027 populations remained predominantly as vegetative cells for longer than did ribotype 001 (20 versus 9 days). The effects of metronidazole on C. difficile were markedly less than expected. Titres of C. difficile ribotype 001 cytotoxin were reduced but recurred following metronidazole administration. C. difficile ribotype 027 cytotoxin titres in the distal section of the gut model were unaffected by metronidazole. These observations correlated with poor metronidazole concentrations.

CONCLUSIONS

Duration of cytotoxin production by C. difficile ribotype 027 markedly exceeds that of ribotype 001. Sub-optimal gut concentrations of metronidazole, possibly due to inactivation by components of normal gut flora, are associated with continued toxin production. These findings may help to explain the increased severity of symptoms and higher case-fatality ratio associated with infections due to C. difficile ribotype 027.

摘要

目的

我们在人体肠道模型中比较了艰难梭菌PCR核糖型001和027的行为,并比较了它们对甲硝唑暴露的反应。

方法

使用接种了混合人粪便的人体肠道模型,在不存在或存在甲硝唑的情况下,测定暴露于克林霉素后肠道菌群细菌计数、艰难梭菌总活菌数、孢子数和细胞毒素滴度。

结果

艰难梭菌核糖型027产生细胞毒素的持续时间明显长于核糖型001(分别为23天和13天),但毒素峰值滴度相似。在毒素产生期间,艰难梭菌核糖型027总菌群体中营养细胞的比例高于核糖型001(中位数分别为56.33%和23.54%)。同样,艰难梭菌核糖型027总菌群体以营养细胞为主的时间比核糖型001更长(分别为20天和9天)。甲硝唑对艰难梭菌的影响明显小于预期。艰难梭菌核糖型001细胞毒素滴度降低,但在给予甲硝唑后又复发。肠道模型远端部分的艰难梭菌核糖型027细胞毒素滴度不受甲硝唑影响。这些观察结果与甲硝唑浓度不足有关。

结论

艰难梭菌核糖型027产生细胞毒素的持续时间明显超过核糖型001。甲硝唑在肠道中的浓度不理想,可能是由于被正常肠道菌群成分灭活,这与毒素持续产生有关。这些发现可能有助于解释与艰难梭菌核糖型027感染相关的症状加重和更高病死率。

相似文献

1
Effect of metronidazole on growth and toxin production by epidemic Clostridium difficile PCR ribotypes 001 and 027 in a human gut model.甲硝唑对人肠道模型中流行的艰难梭菌PCR核糖体分型001和027生长及毒素产生的影响
J Antimicrob Chemother. 2007 Jul;60(1):83-91. doi: 10.1093/jac/dkm113. Epub 2007 May 5.
2
Activity of vancomycin against epidemic Clostridium difficile strains in a human gut model.万古霉素在人体肠道模型中对流行艰难梭菌菌株的活性。
J Antimicrob Chemother. 2009 Mar;63(3):520-5. doi: 10.1093/jac/dkn502. Epub 2008 Dec 26.
3
Tigecycline does not induce proliferation or cytotoxin production by epidemic Clostridium difficile strains in a human gut model.在人体肠道模型中,替加环素不会诱导流行的艰难梭菌菌株增殖或产生细胞毒素。
J Antimicrob Chemother. 2006 Nov;58(5):1062-5. doi: 10.1093/jac/dkl364. Epub 2006 Oct 8.
4
Evaluation of linezolid for the treatment of Clostridium difficile infection caused by epidemic strains using an in vitro human gut model.采用体外人肠道模型评价利奈唑胺治疗流行株引起的艰难梭菌感染。
J Antimicrob Chemother. 2011 Jul;66(7):1537-46. doi: 10.1093/jac/dkr155. Epub 2011 Apr 18.
5
Comparison of oritavancin versus vancomycin as treatments for clindamycin-induced Clostridium difficile PCR ribotype 027 infection in a human gut model.在人体肠道模型中,奥硝唑与万古霉素治疗克林霉素诱导的艰难梭菌PCR核糖体分型027感染的比较。
J Antimicrob Chemother. 2008 Nov;62(5):1078-85. doi: 10.1093/jac/dkn358. Epub 2008 Sep 4.
6
Emergence of reduced susceptibility to metronidazole in Clostridium difficile.艰难梭菌对甲硝唑敏感性降低的出现。
J Antimicrob Chemother. 2008 Nov;62(5):1046-52. doi: 10.1093/jac/dkn313. Epub 2008 Aug 7.
7
[Epidemiological study of Clostridium difficile strains isolated in Jean-Verdier-René-Muret hospitals from 2001 to 2007].[2001年至2007年在让-韦迪耶-勒内-米雷医院分离出的艰难梭菌菌株的流行病学研究]
Pathol Biol (Paris). 2008 Nov-Dec;56(7-8):412-6. doi: 10.1016/j.patbio.2008.07.009. Epub 2008 Oct 7.
8
New PCR ribotypes of Clostridium difficile detected in children in Brazil: prevalent types of Clostridium difficile in Brazil.在巴西儿童中检测到的艰难梭菌新PCR核糖型:巴西艰难梭菌的流行类型
Antonie Van Leeuwenhoek. 2007 Jul;92(1):53-9. doi: 10.1007/s10482-006-9134-2. Epub 2007 Jan 25.
9
The epidemiology of Clostridium difficile in Scotland.苏格兰艰难梭菌的流行病学。
J Infect. 2011 Apr;62(4):271-9. doi: 10.1016/j.jinf.2011.01.015. Epub 2011 Feb 22.
10
Co-amoxiclav induces proliferation and cytotoxin production of Clostridium difficile ribotype 027 in a human gut model.复方新诺明可诱导产毒艰难梭菌 027 型在人体肠道模型中的增殖和细胞毒素产生。
J Antimicrob Chemother. 2012 Apr;67(4):951-4. doi: 10.1093/jac/dkr584. Epub 2012 Jan 25.

引用本文的文献

1
The impact of ibezapolstat and other infection-relevant antibiotics on the microbiome of humanized mice.伊贝扎泊司他及其他与感染相关抗生素对人源化小鼠微生物组的影响。
Antimicrob Agents Chemother. 2025 Apr 2;69(4):e0160424. doi: 10.1128/aac.01604-24. Epub 2025 Feb 25.
2
Influence of microbiota on the growth and gene expression of Clostridioides difficile in an in vitro coculture model.微生物群对体外共培养模型中艰难梭菌生长和基因表达的影响。
Microbiologyopen. 2024 Oct;13(5):e70001. doi: 10.1002/mbo3.70001.
3
Review of the Impact of Biofilm Formation on Recurrent Infection.
生物膜形成对复发性感染影响的综述
Microorganisms. 2023 Oct 10;11(10):2525. doi: 10.3390/microorganisms11102525.
4
Non-Toxigenic Strain E4 (NTCD-E4) Prevents Establishment of Primary Infection by Epidemic PCR Ribotype 027 in an In Vitro Human Gut Model.非产毒菌株E4(NTCD-E4)在体外人肠道模型中可防止流行PCR核糖型027引发原发性感染。
Antibiotics (Basel). 2023 Feb 22;12(3):435. doi: 10.3390/antibiotics12030435.
5
MiniBioReactor Array (MBRA) gut model: a reliable system to study microbiota-dependent response to antibiotic treatment.微型生物反应器阵列(MBRA)肠道模型:一种研究微生物群对抗生素治疗依赖性反应的可靠系统。
JAC Antimicrob Resist. 2022 Jul 5;4(4):dlac077. doi: 10.1093/jacamr/dlac077. eCollection 2022 Aug.
6
2'FL and LNnT Exert Antipathogenic Effects against ATCC 9689 In Vitro, Coinciding with Increased Levels of and/or Secondary Bile Acids.2'-岩藻糖基乳糖(2'FL)和3'-唾液酸乳糖-N-新四糖(LNnT)在体外对ATCC 9689发挥抗致病作用,同时伴随着初级和/或次级胆汁酸水平的升高。
Pathogens. 2021 Jul 22;10(8):927. doi: 10.3390/pathogens10080927.
7
Virulence Factors of () Linked to Recurrent Infections.与复发性感染相关的()的毒力因子 。 (注:括号内内容缺失,无法准确完整翻译)
Can J Infect Dis Med Microbiol. 2019 Dec 24;2019:7127850. doi: 10.1155/2019/7127850. eCollection 2019.
8
Inhibiting Growth of Clostridioides difficile by Restoring Valerate, Produced by the Intestinal Microbiota.通过恢复肠道微生物群产生的正戊酸盐来抑制艰难梭菌的生长。
Gastroenterology. 2018 Nov;155(5):1495-1507.e15. doi: 10.1053/j.gastro.2018.07.014. Epub 2018 Jul 17.
9
The role of toxins in Clostridium difficile infection.毒素在艰难梭菌感染中的作用。
FEMS Microbiol Rev. 2017 Nov 1;41(6):723-750. doi: 10.1093/femsre/fux048.
10
An in silico evaluation of treatment regimens for recurrent Clostridium difficile infection.复发性艰难梭菌感染治疗方案的计算机模拟评估
PLoS One. 2017 Aug 11;12(8):e0182815. doi: 10.1371/journal.pone.0182815. eCollection 2017.